Abstract
This chapter considers various “number needed” (reciprocal or multiplicative inverse) measures of test outcome which can be derived from the basic 2 × 2 contingency table, as well as certain likelihood measures which may be derived from the “number needed” measures. All of these measures, including some described for the first time here, have been developed to summarise test outcome in a manner which is hopefully more intuitive to clinicians and patients than the traditional measures of discrimination such as sensitivity and specificity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andrade C. Likelihood of being helped or harmed as a measure of clinical outcomes in psychopharmacology. J Clin Psychiatry. 2017;78:e73–5.
Citrome L, Ketter TA. When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed. Int J Clin Pract. 2013;67:407–11.
Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452–4.
Habibzadeh F, Yadollahie M. Number needed to misdiagnose: a measure of diagnostic test effectiveness. Epidemiology. 2013;24:170.
Hsieh S, McGrory S, Leslie F, Dawson K, Ahmed S, Butler CR, et al. The Mini-Addenbrooke’s Cognitive Examination: a new assessment tool for dementia. Dement Geriatr Cogn Disord. 2015;39:1–11.
Jaeschke R, Guyatt G, Sackett DL. Users’ guide to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA. 1994;271:703–7.
Kraemer HC. Evaluating medical tests. Objective and quantitative guidelines. Newbery Park, California: Sage; 1992.
Larner AJ. Teleneurology by internet and telephone. A study of medical self-help. London: Springer; 2011.
Larner AJ. Number needed to diagnose, predict, or misdiagnose: useful metrics for non-canonical signs of cognitive status? Dement Geriatr Cogn Dis Extra. 2018;8:321–7.
Larner AJ. MACE for diagnosis of dementia and MCI: examining cut-offs and predictive values. Diagnostics (Basel). 2019;9:E51.
Larner AJ. Applying Kraemer’s Q (positive sign rate): some implications for diagnostic test accuracy study results. Dement Geriatr Cogn Dis Extra. 2019;9:389–96.
Larner AJ. New unitary metrics for dementia test accuracy studies. Prog Neurol Psychiatry. 2019;23(3):21–5.
Larner AJ. Evaluating cognitive screening instruments with the “likelihood to be diagnosed or misdiagnosed” measure. Int J Clin Pract. 2019;73: e13265.
Larner AJ. Manual of screeners for dementia: pragmatic test accuracy studies. London: Springer; 2020.
Larner AJ. Defining “optimal” test cut-off using global test metrics: evidence from a cognitive screening instrument. Neurodegener Dis Manag. 2020;10:223–30.
Larner AJ. Mini-Addenbrooke’s Cognitive Examination (MACE): a useful cognitive screening instrument in older people? Can Geriatr J. 2020;23:199–204.
Larner AJ. Mini-Cog versus Codex (cognitive disorders examination): is there a difference? Dement Neuropsychol. 2020;14:128–33.
Larner AJ. The “attended alone” and “attended with” signs in the assessment of cognitive impairment: a revalidation. Postgrad Med. 2020;132:595–600.
Larner AJ. Communicating risk: developing an “Efficiency Index” for dementia screening tests. Brain Sci. 2021;11:1473.
Larner AJ. The 2 × 2 matrix. Contingency, confusion and the metrics of binary classification. London: Springer; 2021.
Larner AJ. Evaluating binary classifiers: extending the Efficiency Index. Neurodegener Dis Manag. 2022;12:185–94.
Larner AJ. Efficiency index for binary classifiers: concept, extension, and application. Mathematics. 2023;11:2435.
Larner AJ. Cognitive screening in older people using Free-Cog and Mini-Addenbrooke’s Cognitive Examination (MACE). Preprints.org. 2023;2023:2023040237. https://doi.org/10.20944/preprints202304.0237.v1
Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318:1728–33.
Linn S, Grunau PD. New patient-oriented summary measure of net total gain in certainty for dichotomous diagnostic tests. Epidemiol Perspect Innov. 2006;3:11.
McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002;17:647–50.
Mitchell AJ. Index test. In: Kattan MW, editor. Encyclopedia of medical decision making. Los Angeles: Sage; 2009. p. 613–7.
Rembold CM. Number needed to screen: development of a statistic for disease screening. BMJ. 1998;317:307–12.
Rosenthal JA. Qualitative descriptors of strength of association and effect size. J Soc Serv Res. 1996;21:37–59.
Wald NJ, Morris JK. Two under-recognized limitations of number needed to treat. Int J Epidemiol. 2020;49:359–60.
Williamson JC, Larner AJ. “Likelihood to be diagnosed or misdiagnosed”: application to meta-analytic data for cognitive screening instruments. Neurodegener Dis Manag. 2019;9:91–5.
Zermansky A. Number needed to harm should be measured for treatments. BMJ. 1998;317:1014.
Ziso B, Larner AJ. AD8: Likelihood to diagnose or misdiagnose. J Neurol Neurosurg Psychiatry. 2019;90:A20. https://jnnp.bmj.com/content/90/12/A20.1
Ziso B, Larner AJ. Codex (cognitive disorders examination) decision tree modified for the detection of dementia and MCI. Diagnostics (Basel). 2019;9:E58.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Larner, A.J. (2024). Number Needed (Reciprocal) Measures and Their Combinations as Likelihoods. In: The 2x2 Matrix. Springer, Cham. https://doi.org/10.1007/978-3-031-47194-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-47194-0_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-47193-3
Online ISBN: 978-3-031-47194-0
eBook Packages: MedicineMedicine (R0)